Active	Status	Sponsor type	Region	Phase	Filter
5 Active 8 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Kaichun
ES101002, NCT04176588: A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis Dec 2023 - Dec 2023 : Completion of enrollment in phase 3 study of moderate-severe ulcerative colitis	Active, not recruiting	3	341	RoW	Etrasimod, Placebo	Everstar Therapeutics Limited	Moderately to Severely Active Ulcerative Colitis	07/24	10/24
NCT06231264: Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis	Recruiting	N/A	96	RoW	transcutaneous electrical acustimulation at treatment sites, TEA, transcutaneous electrical acustimulation at sham sites, sham-TEA	Xijing Hospital	Ulcerative Colitis	01/25	03/25
NCT06359808: Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis	Recruiting	N/A	152	RoW		Xijing Hospital	Colitis, Ulcerative, Sleep Quality, Gastrointestinal Microbiome, Autonomic Nervous System Imbalance	12/24	12/24
NCT05895981: Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.	Recruiting	N/A	15	RoW	G132 system, Beijing PINS Medical Co., China	Xijing Hospital	Ulcerative Colitis	01/25	03/25
NCT05996458: A Population-based, Multicenter Cohort Study of Combined Screening for Gastrointestinal Tumors	Recruiting	N/A	84000	RoW	Gastroenteroscopy；Risk factor investigation; FIT-HP;RNF180 and SEPTIN9 gene methylation test, Risk factor investigation;	Xijing Hospital	Digestive Disease	11/32	06/33